fashion -WSS

fashion

author：Wikipedia 2025-10-01 22:49:15 - browse：6823

Yichuan Cao/Sipa USA via AP Images

Gilead Sciences said Monday that Trodelvy, its “smart-bomb” medicine that combines an antibody with chemotherapy, did not significantly extend the lives of patients with metastatic non-small cell lung cancer when given after a first treatment failed.

The result, from a closely watched study called Evoke-01, will be seen as a disappointment by investors and oncologists alike.

Drugs like Trodelvy, known as antibody drug conjugates, are one of the hottest areas in oncology. The idea is that these medicines combine an antibody, which is triggered when it binds to a protein on a cancer cell, with a “payload” of chemotherapy that poisons the cancer.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Eli Lilly reports tirzepatide MASH success during Q4 earnings

leisure time

WSS

Congress must protect the remaining independent doctors

Here’s what’s in the FDA plan to include pregnant women in clinical trials

Eli Lilly reports tirzepatide MASH success during Q4 earnings

Bernie Sanders gets little from pharma CEOs on drug prices

Trump indictment: Who are the 'co

Infectious disease expert Jeanne Marrazzo assumes Fauci role

explore

fashion

knowledge

In age of alternative facts, a scholarly course on calling out crap

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Peter Hotez and the public health issue of online harassment

Having children helps parents live longer, especially after age 80

Malaria cases in Florida and Texas: Here’s what you need to know

Latigo launches with $135 million for Vertex

Sports medicine is finally prioritizing gender equality

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

Tori Bowie and the unacceptable rates of Black maternal death

EQRx, failed developer of low

hotspot

Study gives hint on South Asians’ higher risk of cardiovascular disease

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

Sage hopes for a blockbuster in antidepressant now before FDA

What to expect as Trump is arraigned on his Jan 6. indictment

National panel will explore requiring free Covid tests

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

leisure time

entertainment

knowledge

hotspot